Coronary Heart Disease (CHD) in Elderly Patients: Which Drug to Choose, Ticagrelor and Clopidogrel? A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Background: A new generation P2Y12 receptor inhibitor (ticagrelor) is recommended in current therapeutic guidelines to treat patients with coronary heart disease (CHD). However, it is unknown if ticagrelor is more effective than clopidogrel in elderly patients. Therefore, a systematic review was don...

Descripción completa

Detalles Bibliográficos
Autores principales: Akkaif, Mohammed Ahmed, Sha’aban, Abubakar, Daud, Nur Aizati Athirah, Yunusa, Ismaeel, Ng, Mei Li, Sk Abdul Kader, Muhamad Ali, Noor, Dzul Azri Mohamed, Ibrahim, Baharudin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538993/
https://www.ncbi.nlm.nih.gov/pubmed/34677192
http://dx.doi.org/10.3390/jcdd8100123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538993/
https://www.ncbi.nlm.nih.gov/pubmed/34677192
http://dx.doi.org/10.3390/jcdd8100123

Ejemplares similares